Same Indication

Ipilimumab vs Semaglutide

Ipilimumab vs Semaglutide: Overview

This comparison examines the pharmacological differences between Ipilimumab and Semaglutide.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Semaglutide: GLP-1 receptor agonist with enhanced albumin binding for extended action.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Semaglutide — 7 days.

Chemical Properties

Type: Ipilimumab — Antibody; Semaglutide — Protein.